Assenagon Asset Management S.A. Reduces Holdings in Masimo Co. (NASDAQ:MASI)

Assenagon Asset Management S.A. reduced its holdings in Masimo Co. (NASDAQ:MASI - Free Report) by 66.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,773 shares of the medical equipment provider's stock after selling 17,216 shares during the quarter. Assenagon Asset Management S.A.'s holdings in Masimo were worth $1,028,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in MASI. Eminence Capital LP bought a new stake in shares of Masimo during the 3rd quarter worth $90,859,000. Teachers Retirement System of The State of Kentucky boosted its stake in shares of Masimo by 93.8% during the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 16,541 shares of the medical equipment provider's stock worth $1,450,000 after acquiring an additional 8,004 shares in the last quarter. Comerica Bank bought a new stake in shares of Masimo during the 3rd quarter worth $8,454,000. Sei Investments Co. boosted its stake in shares of Masimo by 224.5% during the 3rd quarter. Sei Investments Co. now owns 183,940 shares of the medical equipment provider's stock worth $16,128,000 after acquiring an additional 127,249 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA bought a new stake in shares of Masimo during the 3rd quarter worth $132,699,000. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Masimo Stock Up 1.6 %

Shares of NASDAQ:MASI traded up $2.20 during midday trading on Friday, hitting $142.50. 465,956 shares of the stock were exchanged, compared to its average volume of 541,503. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.22 and a current ratio of 2.18. Masimo Co. has a 52-week low of $75.22 and a 52-week high of $198.00. The business's fifty day simple moving average is $134.37 and its two-hundred day simple moving average is $111.31. The company has a market capitalization of $7.54 billion, a PE ratio of 94.37 and a beta of 0.97.

Masimo (NASDAQ:MASI - Get Free Report) last announced its quarterly earnings data on Tuesday, February 27th. The medical equipment provider reported $1.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.82 by $0.43. Masimo had a return on equity of 13.77% and a net margin of 3.98%. The business had revenue of $548.90 million during the quarter, compared to analyst estimates of $545.69 million. During the same period last year, the company earned $1.32 earnings per share. Masimo's quarterly revenue was down 11.0% compared to the same quarter last year. As a group, research analysts predict that Masimo Co. will post 3.51 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. StockNews.com raised Masimo from a "sell" rating to a "hold" rating in a research note on Friday, March 29th. Needham & Company LLC lowered Masimo from a "buy" rating to a "hold" rating in a research note on Wednesday, January 3rd. Jefferies Financial Group reaffirmed a "hold" rating and issued a $121.00 target price (up previously from $107.00) on shares of Masimo in a research report on Tuesday, January 30th. BTIG Research raised their target price on Masimo from $145.00 to $166.00 and gave the stock a "buy" rating in a research report on Monday, March 25th. Finally, Stifel Nicolaus raised their target price on Masimo from $125.00 to $148.00 and gave the stock a "hold" rating in a research report on Monday, March 25th. Six research analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $134.29.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.